Evidence map›Paper›PMID 33980630›Full record

ArticleCanadian family physician Medecin de famille canadien2021

Pharmacotherapy management of schizophrenia for family physicians.

Japheth Bool, Alex Crawley, Annabelle Wanson, Breanna Davis, Katelyn Halpape

Abstract read
In one paragraph

Article in Canadian family physician Medecin de famille canadien, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Thoughtful prescribing for patients with difficult-to-treat depression.Canadian family physician Medecin de famille canadien · 2023
    Article
  2. Article
  3. Cognitive dysfunction and disability in people living with schizophrenia.Journal of family medicine and primary care · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Japheth BoolPharmacy student at the University of Saskatchewan in Saskatoon.
Alex CrawleyAssociate Director of RxFiles Academic Detailing in the College of Pharmacy and Nutrition at the University of Saskatchewan.
Annabelle WansonAssistant Professor in the College of Medicine at the University of Saskatchewan and Inpatient Psychiatry Lead in the Irene and Leslie Dube Centre at the Royal University Hospital in Saskatoon.
Breanna DavisAssistant Professor in the Department of Academic Family Medicine at the University of Saskatchewan and a family physician in Prince Albert, Sask.
Katelyn HalpapeAssistant Professor in the College of Pharmacy and Nutrition at the University of Saskatchewan and a clinical psychiatric pharmacist in Saskatoon. Katelyn.halpape@usask.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antipsychotic AgentsSchizophreniaHumansMedication Therapy ManagementPhysicians, FamilyAntipsychotic Agents

Identifiers

PMID33980630
PMCPMC8115962

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.